The U.S. Department of Labor has issued new data showing California's State Average Weekly Wage (SAWW) edged down 0.48 percent from $1,650 to $1,642 in the 12 months ending March 31, 2023. As a result...
CALIFORNIA COMPENSATION CASES Vol. 88, No. 11 November 2023 A Report of En Banc and Significant Panel Decisions of the WCAB and Selected Court Opinions of Related Interest, With a Digest of WCAB Decisions...
By Hon. Susan V. Hamilton, Former Assistant Secretary and Deputy Commissioner, California Workers’ Compensation Appeals Board Nearly two decades ago Senate Bill 899 was enacted and ushered in a...
LexisNexis has selected some recently issued noteworthy IMR decisions that illustrate the criteria that must be met to obtain authorization for a variety of different medical treatment modalities. LexisNexis...
By Hon. Susan V. Hamilton, Former Assistant Secretary and Deputy Commissioner, California Workers’ Compensation Appeals Board Early in the COVID-19 pandemic we learned that nursing care facilities...
The Supreme Court of Minnesota held that an injured worker had failed to establish that his long-term use of Endocet—an opioid—was in line with long-term treatment parameters established pursuant to Minn. R. 5221.6110 (2019). Accordingly, his continued treatment via the opioid was not reasonable and necessary and need not be provided by the employer. The worker sustained his injury in 2002, before the opioid treatment parameters were promulgated. His pain had never fully responded to conservative treatment. The compensation judge found that the worker had established that the Endocet treatment was compensable as a “rare case” under our decision in Jacka v.Coca-Cola Bottling Co., 580 N.W.2d 27, 32 (Minn. 1998), because the worker experienced unbearable pain without the Endocet and the medication reduced his pain by one-half, allowing him to engage more fully in the activities of daily living. The Court found, however, that the legislature had determined that in all but the most exceptional circumstances, the treatment parameters best achieved the objectives of the workers’ compensation system. The worker had failed to establish that he continued use of the opioid was an exceptional circumstance.
Thomas A. Robinson, J.D., the co-Editor-in-Chief and Feature National Columnist for the LexisNexis Workers’ Compensation eNewsletter, is co-author of Larson’s Workers’ Compensation Law(LexisNexis).
LexisNexis Online Subscribers: Citations below link to Lexis Advance.
See Johnson v. Darchuks Fabrications, 2021 Minn. LEXIS 423 (Aug. 18, 2021)
See generally Larson’s Workers’ Compensation Law, § 94.03.
Source: Larson’s Workers’ Compensation Law, the nation’s leading authority on workers’ compensation law
For a more detailed discussion of the case, see
Sign up for the free LexisNexis Workers’ Compensation enewsletter at www.lexisnexis.com/wcnews.